Suchergebnisse - "Tan, Qiaoyun"

PubPharm (6)

1

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

2

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology immunotherapy | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

3

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology, immunotherapy : CII | 2022

von Tan, Q. | Dai, L. | Wang, Y. | +20

4

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology immunotherapy | 2021

von Tan, Q. | Dai, L. | Wang, Y. | +20

5

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy

enthalten in: Cancer immunology immunotherapy | 2021

von Tan, Q. | Dai, L. | Wang, Y. | +20

6

Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients

enthalten in: Theranostics | 2020

von Tan, Q. | Wang, D. | Yang, J. | +24

1
[1]